CLINICAL PHARMACOKINETICS OF PROCAINAMIDE

被引：52

作者：

KARLSSON, E

机构：

来源：

关键词：

D O I：

10.2165/00003088-197803020-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：97 / 107

页数：11

共 51 条

[1] ARSTILA M, 1974, ACTA MED SCAND, V195, P217
[2] ATKINSON AJ, 1976, CLIN PHARMACOL THER, V20, P585
[3] ATKINSON AJ, 1977, CLIN PHARMACOL THER, V21, P575
[4] ATKINSON AJ, 1972, CLIN CHEM, V18, P643
[5] PHARMACOKINETICS IN PATIENTS WITH CARDIAC-FAILURE
BENOWITZ, NL
MEISTER, W
[J]. CLINICAL PHARMACOKINETICS, 1976, 1 (06) : 389 - 405
[6] BRECKENRIDGE A, 1971, ACTA PHARMACOL TOX, V29, P225
[7] ACETYLATOR PHENOTYPE AND CLINICAL PHARMACOLOGY OF SLOW-RELEASE PROCAINAMIDE
CAMPBELL, W
TILSTONE, WJ
LAWSON, DH
HUTTON, I
LAWRIE, TDV
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (06) : 1023 - 1026
[8] COLLSTE P, 1973, ACTA MED SCAND, V194, P405
[9] ANTINUCLEAR ANTIBODIES DURING PROCAINAMIDE TREATMENT AND DRUG ACETYLATION
DAVIES, DM
BEEDIE, MA
RAWLINS, MD
[J]. BRITISH MEDICAL JOURNAL, 1975, 3 (5985) : 682 - 684
[10] DREYFUSS J, 1972, CLIN PHARMACOL THER, V13, P366